On the afternoon of February 15, 2024 (the 6th day of the Lunar New Year), BIDIPHAR – Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company was honored to welcome Mr. Ho Quoc Dung, Member of the Central Committee of Vietnam Communist Party, Binh Dinh Provincial Party Committee Secretary, Chairman of Binh Dinh Provincial People’s Council, along with leaders of provincial departments to visit, extend New Year greetings, and inspect the company’s production and business operations at the Nhon Hoi High-Tech Factory.
On behalf of the company’s board of directors, Ms. Pham Thi Thanh Huong, General Director of BIDIPHAR, expressed her joy at welcoming the delegation. On this occasion, she reported on the company’s production and business operations in 2023 with many highlights: revenue from manufacturing this year reached 1,658 billion VND, an increase of 10% compared to 2022; profit before tax reached 320 billion VND, an increase of 7% compared to 2022; contributed more than 2 billion VND to community activities, ensuring an average income for employees of 10 million VND/person/month.
Ready to enter 2024 with many challenges, BIDIPHAR sets a revenue target of 2,000 billion VND; profit before tax of 320 billion VND; complete GMP-EU implementation for the cancer treatment drug line; ensure the progress of construction of the small-volume sterile drug manufacturing plant according to EU-GMP standards; continue to promote digitization; communicate corporate culture; professionalize the workforce, create differentiation in products and production technology…
At the meeting, Mr. Ho Quoc Dung acknowledged, commended, and highly appreciated the achievements and contributions of the company to the socio-economic development of the province in 2023.
Entering the new year, he asked BIDIPHAR to continue to promote achievements, expand production and business, and conquer new milestones. He also acknowledged the company’s recommendations and committed to creating all favorable conditions for the company to develop production and business, solve employment for workers, contribute to the budget, improve workers’ income, and continue to promote and maintain the brand of the leading pharmaceutical company in Vietnam.
